Benjamin F. Edwards & Company, Inc. Quest Diagnostics Inc Transaction History

Benjamin F. Edwards & Company, Inc.

$5.69 Billion
Q2 2024

A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 111 shares of DGX stock, worth $15,216. This represents 0.0% of its overall portfolio holdings.

Number of Shares

111

Previous 159 30.19%

Holding current value

$15,216

Previous $21,000 28.57%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$125.91 - $144.34 $6,043 - $6,928	-48 Reduced 30.19%	111 $15,000
Q1 2024 Apr 29, 2024	SELL	$123.78 - $142.11 $1.33 Million - $1.53 Million	-10,738 Reduced 98.54%	159 $21,000
Q4 2023 Feb 06, 2024	BUY	$120.62 - $141.12 $165,611 - $193,757	1,373 Added 14.42%	10,897 $1.5 Million
Q3 2023 Nov 13, 2023	BUY	$121.86 - $144.92 $86,520 - $102,893	710 Added 8.06%	9,524 $1.16 Million
Q2 2023 Aug 15, 2023	BUY	$130.56 - $146.84 $1.08 Million - $1.22 Million	8,277 Added 1541.34%	8,814 $1.24 Million
Q1 2023 Apr 27, 2023	SELL	$131.53 - $155.76 $13,284 - $15,731	-101 Reduced 15.83%	537 $76,000
Q4 2022 Feb 07, 2023	BUY	$123.31 - $157.26 $41,432 - $52,839	336 Added 111.26%	638 $100,000
Q3 2022 Oct 28, 2022	SELL	$121.77 - $141.1 $59,423 - $68,856	-488 Reduced 61.77%	302 $37,000
Q2 2022 Aug 12, 2022	SELL	$127.07 - $145.39 $28,209 - $32,276	-222 Reduced 21.94%	790 $105,000
Q1 2022 May 04, 2022	BUY	$129.09 - $164.35 $7,358 - $9,367	57 Added 5.97%	1,012 $139,000
Q3 2021 Nov 02, 2021	BUY	$132.95 - $158.0 $3,057 - $3,634	23 Added 2.47%	955 $139,000
Q2 2021 Aug 11, 2021	SELL	$126.66 - $141.48 $11,146 - $12,450	-88 Reduced 8.63%	932 $123,000
Q1 2021 May 14, 2021	SELL	$114.63 - $133.34 $10,202 - $11,867	-89 Reduced 8.03%	1,020 $131,000
Q4 2020 Feb 16, 2021	BUY	$112.7 - $128.05 $35,838 - $40,719	318 Added 40.2%	1,109 $132,000
Q3 2020 Nov 13, 2020	BUY	$107.05 - $130.01 $66,692 - $80,996	623 Added 370.83%	791 $91,000
Q2 2020 Aug 14, 2020	BUY	$73.34 - $122.61 $1,980 - $3,310	27 Added 19.15%	168 $19,000
Q1 2020 May 07, 2020	SELL	$75.14 - $115.68 $59,210 - $91,155	-788 Reduced 84.82%	141 $11,000
Q4 2019 Feb 06, 2020	BUY	$100.29 - $107.99 $79,028 - $85,096	788 Added 558.87%	929 $99,000
Q3 2019 Nov 05, 2019	SELL	$97.85 - $107.42 $42,466 - $46,620	-434 Reduced 75.48%	141 $15,000
Q2 2019 Aug 08, 2019	BUY	$85.18 - $101.94 $6,729 - $8,053	79 Added 15.93%	575 $59,000
Q1 2019 May 15, 2019	SELL	$80.68 - $89.92 $3,872 - $4,316	-48 Reduced 8.82%	496 $45,000
Q4 2018 Jan 31, 2019	BUY	$79.75 - $108.38 $10,686 - $14,522	134 Added 32.68%	544 $45,000
Q3 2017 Oct 24, 2017	BUY	$91.96 - $108.35 $37,703 - $44,423	410	410 $38,000

Others Institutions Holding DGX

# of Institutions

924

Shares Held

95.1M

Call Options Held

361K

Put Options Held

346K

View Full List

About QUEST DIAGNOSTICS INC

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

More about DGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.

Account

Benjamin F. Edwards & Company, Inc. Quest Diagnostics Inc Transaction History